IL17A and cancer: revealed that Tc17-derived IL-17A and TNF activate cancer-associated fibroblasts (CAFs), inducing their differentiation into inflammatory CAFs (iCAFs), thereby establishing a Tc17-iCAF feedback loop that exacerbates immunosuppression and tumor progression (75).